Effects on postoperative nausea and vomiting of nefopam versus fentanyl following bimaxillary orthognathic surgery: a prospective double-blind randomized controlled trial
10.17245/jdapm.2019.19.1.55
- Author:
Eunhye CHOI
1
;
Myong Hwan KARM
;
Eunsun SO
;
Yoon Ji CHOI
;
Sookyung PARK
;
Yul OH
;
Hye Joo YUN
;
Hyun Jeong KIM
;
Kwang Suk SEO
Author Information
1. Department of Dental Anesthesiology, School of Dentistry, Seoul National University, Seoul, Republic of Korea. stone90@snu.ac.kr
- Publication Type:Randomized Controlled Trial
- Keywords:
Fentanyl;
Nefopam;
Patient-Controlled Analgesia;
Postoperative Nausea And Vomiting
- MeSH:
Analgesia, Patient-Controlled;
Analgesics, Opioid;
Fentanyl;
Fracture Healing;
Gastrointestinal Tract;
Humans;
Incidence;
Nefopam;
Orthognathic Surgery;
Pain, Postoperative;
Passive Cutaneous Anaphylaxis;
Postoperative Nausea and Vomiting;
Prospective Studies;
Recovery Room
- From:Journal of Dental Anesthesia and Pain Medicine
2019;19(1):55-66
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: Postoperative nausea and vomiting (PONV) frequently occurs following bimaxillary orthognathic surgeries. Compared to opioids, Nefopam is associated with lower incidences of PONV, and does not induce gastrointestinal tract injury, coagulopathy, nephrotoxicity, or fracture healing dysfunction, which are common side effects of Nonsteroidal anti-inflammatory drugs. We compared nefopam- and fentanyl-induced incidence of PONV in patients with access to patient-controlled analgesia (PCA) following bimaxillary orthognathic surgeries. METHODS: Patients undergoing bimaxillary orthognathic surgeries were randomly divided into nefopam and fentanyl groups. Nefopam 120 mg or fentanyl 700 µg was mixed with normal saline to a final volume of 120 mL. Patients were given access to nefopam or fentanyl via PCA. Postoperative pain intensity and PONV were measured at 30 minutes and 1 hour after surgery in the recovery room and at 8, 24, 48, and 72 hours after surgery in the ward. The frequency of bolus delivery was compared at each time point. RESULTS: Eighty-nine patients were enrolled in this study, with 48 in the nefopam (N) group and 41 in the fentanyl (F) group. PONV occurred in 13 patients (27.7%) in the N group and 7 patients (17.1%) in the F group at 8 hours post-surgery (P = 0.568), and there were no significant differences between the two groups at any of the time points. VAS scores were 4.4 ± 2.0 and 3.7 ± 1.9 in the N and F groups, respectively, at 8 hours after surgery (P = 0.122), and cumulative bolus delivery was 10.7 ± 13.7 and 8.6 ± 8.5, respectively (P = 0.408). There were no significant differences in pain or bolus delivery at any of the remaining time points. CONCLUSION: Patients who underwent bimaxillary orthognathic surgery and were given nefopam via PCA did not experience a lower rate of PONV compared to those that received fentanyl via PCA. Furthermore, nefopam and fentanyl did not provide significantly different postoperative pain control.
